Using regenerative lipid mediators to improve healing of severe burn wounds
Regenerative Lipid Mediators for the Management of Severe Burn Wounds
This study is exploring a new way to help people with severe burn injuries heal better by using special cells and a gel that releases healing substances, making it easier for their skin to recover and grow back.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10576811 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapies for severe burn injuries, which often require skin grafts that are limited by donor site availability and complications. The approach involves using mesenchymal stem cells (MSCs) and adipose-tissue derived microvascular fragments (MVFs) to enhance the healing process. By creating a hydrogel that releases regenerative lipid mediators (ReLiMs), the study aims to sustain the healing factors in burn wounds, promoting better tissue regeneration and vascularization. This method seeks to address the limitations of current treatments and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from severe burn injuries who may benefit from advanced regenerative therapies.
Not a fit: Patients with minor burns or those who do not have access to the necessary treatment facilities may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for severe burn injuries, reducing healing time and improving recovery outcomes for patients.
How similar studies have performed: Previous research has shown promise in using stem cells and regenerative therapies for wound healing, indicating potential success for this novel approach.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: Hong, Song — Lsu Health Sciences Center
- Study coordinator: Hong, Song
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.